The Thai Cabinet has given the go-ahead for the Public Health Ministry to purchase 50,000 remedy programs of the antiviral capsule, Molnupiravir. The drug, from US manufacturer Merck, is the world’s first oral therapy for Covid-19 and has been proven to chop the danger of hospitalisation if administered within days of symptoms creating.
According to a Bangkok Post report, Health Minister Anutin Charnvirakul says the drug shall be used to deal with sufferers in high-risk teams, together with these over the age of 60 and people with underlying well being conditions that put them at larger danger of growing extreme signs or dying from Covid-19. For sufferers with delicate symptoms, Anutin says they’ll be given the antiviral drug Favipiravir in the early phases.
“ ผลไม้แช่อิ่ม of Favipiravir prices 1,000 baht or more, if imported, whereas a course of Molnupiravir costs about 10,000 baht. Doctors will decide tips on how to use them. In making a buy order, we must think about high quality. We are not stingy, but every baht spent must be price it.”
The Bangkok Post stories that there has been no affirmation from Anutin on when the ministry might order Molnupiravir or when it might arrive in the kingdom. The treatment is being marketed beneath the brand identify Lagevrio.
For more information on Covid-19 Insurance, CLICK HERE.
SOURCE: Bangkok Post